Cite
HARVARD Citation
Hsu, B. et al. (n.d.). SAT0182 Improvement in Measures of Depressed Mood and Anhedonia, and Fatigue, In a Randomized, Placebo-Controlled, Phase 2 Study of Sirukumab, A Human Anti-Interleukin-6 Antibody, In Patients with Rheumatoid Arthritis. Annals of the rheumatic diseases. pp. 720-721. [Online].